Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 6479

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.30, p 0.426). This receipt's hash covers every field on it, plus the hash of receipt 6478, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 6479
    22 Oct 2026, 13:34 UTC

    RRN3

    oligodendrocytes, braak

    predictionRRN3 in oligodendrocytes tracks Braak Lewy-body stage

    registereda08a661eecf42405

    discovery+0.30 p=0.426 n=9

    replication-0.23 p=0.545 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.30, p 0.426)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    9398e1ecdce1faf2dbe87d65…
    follows e87535ee329c…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 6479: RRN3 in oligodendrocytes, braak

power
full sample +0.03 (p 0.922, n 18), 95% CI -0.45 to +0.49. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.00 (p 0.997, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.09 (p 0.715, n 18). could be the mix.
skeptic
leave-one-out range -0.05 to +0.19, sign flips 9; without severely affected donors +0.03 (p 0.922, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for RRN3 in oligodendrocytes.

case closed: nothing better to follow up.